- Home
- MOLN vs MVST Comparison
MOLN vs MVST Comparison
Compare MOLN & MVST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MOLN
- MVST
- Stock Information
- Founded
- MOLN 2004
- MVST 2006
- Country
- MOLN Switzerland
- MVST United States
- Employees
- MOLN N/A
- MVST N/A
- Industry
- MOLN
- MVST Industrial Machinery/Components
- Sector
- MOLN
- MVST Miscellaneous
- Exchange
- MOLN Nasdaq
- MVST Nasdaq
- Market Cap
- MOLN 136.1M
- MVST 1.3B
- IPO Year
- MOLN 2021
- MVST N/A
- Fundamental
- Price
- MOLN $3.76
- MVST $3.61
- Analyst Decision
- MOLN
- MVST Strong Buy
- Analyst Count
- MOLN 0
- MVST 1
- Target Price
- MOLN N/A
- MVST $3.00
- AVG Volume (30 Days)
- MOLN 1.8K
- MVST 9.2M
- Earning Date
- MOLN 08-25-2025
- MVST 08-07-2025
- Dividend Yield
- MOLN N/A
- MVST N/A
- EPS Growth
- MOLN N/A
- MVST N/A
- EPS
- MOLN N/A
- MVST N/A
- Revenue
- MOLN $2,525,030.00
- MVST $414,941,000.00
- Revenue This Year
- MOLN N/A
- MVST $26.08
- Revenue Next Year
- MOLN $866.67
- MVST $29.71
- P/E Ratio
- MOLN N/A
- MVST N/A
- Revenue Growth
- MOLN N/A
- MVST 21.68
- 52 Week Low
- MOLN $3.36
- MVST $0.15
- 52 Week High
- MOLN $12.22
- MVST $4.72
- Technical
- Relative Strength Index (RSI)
- MOLN 49.47
- MVST 48.33
- Support Level
- MOLN $3.71
- MVST $3.42
- Resistance Level
- MOLN $3.89
- MVST $4.27
- Average True Range (ATR)
- MOLN 0.16
- MVST 0.32
- MACD
- MOLN 0.01
- MVST -0.11
- Stochastic Oscillator
- MOLN 41.27
- MVST 17.69
About MOLN Molecular Partners AG
Molecular Partners AG is a clinical stage biopharmaceutical company. The Company has programs in various stages of pre-clinical and clinical development, with oncology as its main focus. The firm develops protein therapeutics called DARPin therapeutics for the treatment of serious diseases, including cancer and sight-threatening disorders. The company's product pipeline is organized principally through three areas: Ophthalmology, including the creation of therapies for retinal diseases like wet age-related macular degeneration and diabetic macular edema; the Oncology pipeline comprises DARPin candidates with novel modes of action, including multi-DARPin compounds; and Immuno-oncology for anticancer treatment.
About MVST Microvast Holdings Inc.
Microvast Holdings Inc is a technology innovator that designs, develops, and manufactures lithium-ion battery solutions. It is renowned for its cutting-edge cell technology and its vertical integration capabilities which extends from core battery chemistry to battery packs.